Bio
Peter Llewellyn-Davies is an experienced biotech executive with over 40 years of international
expertise in company formation, IPOs, M&A, and financing. As Founder & CEO of Accellerate
Partners, he supports management teams in scaling and implementing growth strategies. He is
Founder and President of BIOTECH AUSTRIA, serves as Chairman of ARTCLINE GmbH, Non-Executive Director of Shield
Therapeutics plc, and co-founded invIOs, a company developing innovative cancer
immunotherapies, including treatments for brain tumors (glioblastoma). Previously, he led the
restructuring and successful sale of Apeiron Biologics to a U.S. pharmaceutical group. Peter
has been recognized as a Fellow of the London Institute for Banking and Finance for his
contributions to global finance
CEO of the Year 2025 
 |
Season |
Rank |
Move |
Points |
|
| 2025 |
#949 |
- |
<10 |
|
Title to be awarded: World CEO of the Year 2026
 |
Season |
Rank |
Move |
Points |
|
| 2025 |
#27 |
- |
<10 |
|
Title to be awarded: Austria CEO of the Year 2026
 |
Season |
Rank |
Move |
Points |
|
| 2025 |
#4 |
- |
<10 |
|
Title to be awarded: Oberösterreich CEO of the Year 2026
 |
Season |
Rank |
Move |
Points |
|
| 2025 |
#1 |
- |
<10 |
|
Title to be awarded: Altmünster CEO of the Year 2026
Performance Excellence Award 2026 
| Season |
Rank |
Points |
|
| 2026 |
#949 |
<10 |
|
Corporate Support Award 2026 
| Season |
Rank |
Points |
|
| 2026 |
#949 |
<10 |
|
Supporters
The list is still empty. Be the first to show your support!
Support Peter as a company or organization
People’s Choice Award 2025 
| Season |
Rank |
Points |
|
| 2025 |
#949 |
<10 |
|
All-Time Rankings
| Current Rank |
Peak |
Total Points |
|
| #2088 |
#2088 in 2025 |
<10 |
|
Vote
Individuals can vote for themselves or their family. Companies or organizations can submit a number of votes equal to their employee count.
Company or Organization
VOTE
Norman McDonnell
Nino Lo Iacono
Peter Llewellyn-Davies
